Stay updated on Oral Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision label 'Revision: v3.3.2' was added and the previous 'Revision: v3.3.1' label was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page now shows Revision: v3.3.1, replacing Revision: v3.2.0. This is a minor metadata update and does not affect the study details or user-facing content.SummaryDifference0.1%

- Check29 days agoChange DetectedThe bottom funding/operating-status disclaimer has been removed from the page.SummaryDifference0.4%

- Check43 days agoChange DetectedThe page shows only minor formatting and wording edits; core study data such as eligibility, outcomes, enrollment, and locations appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%

- Check79 days agoChange DetectedThe page has been updated to version v3.1.0 and several related topics (MedlinePlus topics on drug safety and counterfeit/substandard drugs) have been removed. Overall, this is a minor, metadata-level update with no new core content or time-sensitive information added.SummaryDifference0.6%

Stay in the know with updates to Oral Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page.